_pennystock版 - Spectrum Pharmaceuticals’ Pivotal Registrational Study of Belinostat |
|---|
|
|
|
|
|
B****A
发帖数: 816 | 1 Independent Data Monitoring Committee Recommends Continuation of Spectrum
Pharmaceuticals’ Pivotal Registrational Study of Belinostat in Peripheral T
-Cell Lymphoma
•Independent Data Monitoring Committee (DMC) Recommends That the
BELIEF Study Continue According to Protocol Until 100 Evaluable Patients
Enrolled
•No Safety Concerns Raised Based on DMC Safety Analysis
http://www.businesswire.com/news/home/20110328005575/en/Indepen | L**i
发帖数: 22365 | |
|
|
|
|
|
|
